Connecticut · 86665

Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Connecticut

Connecticut Medicare Avg
$17.01
4% below national avg
National Medicare Avg
$17.73
All states combined
Billed Charge (CT)
$72.18
What providers submit
Est. Commercial (CT)
$43.37
National avg: $39.71
Est. Cash / Self-Pay (CT)
$32.60
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

54
Services in CT
13
Providers
N/A
Min Payment
N/A
Max Payment

Connecticut Pricing in Context

In Connecticut, CPT code 86665 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid) carries an average Medicare payment of $17.01 — 4% below the national benchmark of $17.73. 13 providers across the state submitted claims for this procedure in 2023, performing 54 total services. Individual payments in CT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Connecticut is $72.18, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Connecticut sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Connecticut lands near $43.37, with self-pay cash prices typically around $32.60. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost in Connecticut?

The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Connecticut is $17.01, which is 4% below the national average of $17.73. Providers in CT typically bill $72.18 for this procedure.

What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cost with insurance in Connecticut?

With commercial insurance in Connecticut, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs an estimated $43.37. Without insurance, the estimated cash price is $32.60. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in Connecticut?

13 providers in Connecticut billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid in 2023, performing 54 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid cheaper in Connecticut than the national average?

Yes — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Viral Capsid costs 4% below the national average in Connecticut. The state average Medicare payment is $17.01 compared to $17.73 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial